Search results for " investors"
Article
Biopharma Seeks Balance
… on effective drug products for health or survival; regulatory authorities that monitor quality; and investors that demand financial performance. Maintaining a balance of multiple, sometimes conflict…
Article
Science Focus Fuels Successful Process Development for Startups
They lack access to revenue streams from existing drug sales to fund their process development efforts, so money must be raised, which requires convincing investors that the ideas they are developing …
Article
Contract Manufacturing Through the Years
Low valuations and low interest rates combined to provide savvy investors the opportunity to get into an industry whose long-term prospects looked very attractive. The private equity firms brought new…
Article
Healthcare Reform in China
An appealing market
The Chinese market is attractive to foreign investors for many reasons. It is the world’s third largest market for pharmaceuticals with annual sale of US$71 billion. In fact, i…
Article
CDMOs Driving Emerging Bio/Pharma Success
Relative to what they could expect 10 or more years ago, investors in emerging bio/pharma companies today can put up less money and get proof of concept more quickly, for the following reasons:
…
Article
The Tide Stays High
However, emerging bio/pharma investors haven’t been moved much by this news as the NBI has remained at the same level it has been at for the past 12 months.
Enthusiasm for the bio/pharma industry …
Article
Report: Branded Biopharms Most Exposed to Biosimilar Competition
Source: Moody's Investors Service
Article
Climate Change in Outsourcing
…pitalists to realize large gains on their bio/pharmaceutical companies’ investments and encouraged investors to reenter the market.
Rising opportunities
As these forces reshape the bio/pharma…
Article
Bracing for a Future Wave of Advanced Therapies
With the help of recent investor interest, progression of advanced therapy medicinal products (ATMPs) in the clinical space continues to move forward. Buoyed by the regulatory approval of sever…
Article
Innovation vs. Capacity: How CMOs Compete
The strategies of an innovation-driven CMO may be different than a capacity-driven CMO.
By Jim Miller
While industry participants and observers talk about the “CMO industry,” they know that …